PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS.

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Abstract Text:

A F GARDNER,M A ROTHMAN,

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Publishing Authors By Initials

AF GARDNER,MA ROTHMAN,

For similar musculoskeletal diseases: bone diseases: osteitis deformans research abstracts see: musculoskeletal diseases: bone diseases: osteitis deformans research

PUBMED ID PMID:

MEDLINE DATE:

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal - Connecticut State Dental Association

VOLUME: 39

Page Numbers: 31-6

Journal Abbreviation:

ISSN: 0010-6232

DAY: 18

MONTH: Apr

YEAR: 1965

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7507166

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Keywords Mesh Terms:

KEYWORDS: Osteitis Deformans

MESH TERMS:

Chemical & Substance for Abstract: PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Conn State Dent Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

PAGET'S DISEASE WITH INVOLVEMENT OF THE ORAL REGIONS Related Publications

• A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
• Addressing the diabetes pandemic: a comprehensive approach.
• Cell-based assays using primary endothelial cells to study multiple steps in inflammation.
• Commentary: Epidemiology still ascendant.
• Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
• Does "excessive" anticoagulation predispose to periprosthetic infection?
• Fungus infections of the skin.
• Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
• High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo.
• Hypertrichosis lanuginosa?
• Impact of weight loss on the metabolic syndrome.
• Irritable bowel syndrome and hysterectomy: a sequence symmetry analysis.
• Maternal deployment of the embryonic SKN-1-->MED-1,2 cell specification pathway in C. elegans.
• Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2-13C] glucose.
• Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
• Not Available
• PIP3 pathway in regulatory T cells and autoimmunity.
• Pharmacokinetic variability and modern epidemiology--the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort.
• Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts.
• Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
• Primary total hip arthroplasty with an uncemented femoral component: two- to seven-year results.
• Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission.
• Regulation of developmental rate and germ cell proliferation in Caenorhabditis elegans by the p53 gene network.
• Relationship of thrombopoietin and interleukin-11 levels to thrombocytopenia associated with dengue disease.
• Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
• Scaling of dynamic contact angles in a lattice-Boltzmann model.
• Suppressor of cytokine signaling in allergic inflammation.
• The Mayo Clinic manuscript series relative to the discussion, dissemination, and operationalization of the Food and Drug Administration guidance on patient-reported outcomes.
• The effectiveness of gain-framed messages for encouraging disease prevention behavior: is all hope lost?
• The rise and fall of epidemiology, 1950-2000 A.D. 1981.